Danaher Corporation (0R2B.L)
USD 178.02
(-1.24%)
USD 178.02
(-1.24%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 30.99 Billion USD | -9.52% |
| 2022 | 34.26 Billion USD | -9.86% |
| 2021 | 38 Billion USD | 4.46% |
| 2020 | 36.38 Billion USD | 14.42% |
| 2019 | 31.79 Billion USD | 62.2% |
| 2018 | 19.6 Billion USD | -3.33% |
| 2017 | 20.28 Billion USD | -8.72% |
| 2016 | 22.21 Billion USD | -9.16% |
| 2015 | 24.45 Billion USD | 80.61% |
| 2014 | 13.54 Billion USD | 10.81% |
| 2013 | 12.22 Billion USD | -11.81% |
| 2012 | 13.85 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 29.31 Billion USD | 2.29% |
| 2024 Q2 | 28.65 Billion USD | -4.35% |
| 2024 Q1 | 29.95 Billion USD | -3.36% |
| 2023 Q2 | 33.17 Billion USD | -1.12% |
| 2023 FY | 30.99 Billion USD | -9.52% |
| 2023 Q4 | 30.99 Billion USD | -12.23% |
| 2023 Q1 | 33.55 Billion USD | -2.06% |
| 2023 Q3 | 35.31 Billion USD | 6.45% |
| 2022 Q4 | 34.26 Billion USD | 0.66% |
| 2022 FY | 34.26 Billion USD | -9.86% |
| 2022 Q3 | 34.03 Billion USD | -3.32% |
| 2022 Q2 | 35.2 Billion USD | -4.93% |
| 2022 Q1 | 37.03 Billion USD | -2.57% |
| 2021 Q1 | 34.99 Billion USD | -3.81% |
| 2021 FY | 38 Billion USD | 4.46% |
| 2021 Q3 | 39.03 Billion USD | 10.71% |
| 2021 Q4 | 38 Billion USD | -2.64% |
| 2021 Q2 | 35.26 Billion USD | 0.76% |
| 2020 Q1 | 37.86 Billion USD | 19.07% |
| 2020 Q3 | 34.91 Billion USD | -0.22% |
| 2020 FY | 36.38 Billion USD | 14.42% |
| 2020 Q4 | 36.38 Billion USD | 4.2% |
| 2020 Q2 | 34.99 Billion USD | -7.58% |
| 2019 Q1 | 20.2 Billion USD | 3.06% |
| 2019 FY | 31.79 Billion USD | 62.2% |
| 2019 Q4 | 31.8 Billion USD | 12.23% |
| 2019 Q3 | 28.33 Billion USD | 34.24% |
| 2019 Q2 | 21.1 Billion USD | 4.47% |
| 2018 Q4 | 19.6 Billion USD | -2.14% |
| 2018 Q2 | 20.83 Billion USD | 4.45% |
| 2018 Q1 | 19.94 Billion USD | -1.66% |
| 2018 FY | 19.6 Billion USD | -3.33% |
| 2018 Q3 | 20.03 Billion USD | -3.83% |
| 2017 Q2 | 21.05 Billion USD | -1.88% |
| 2017 FY | 20.28 Billion USD | -8.72% |
| 2017 Q1 | 21.45 Billion USD | -3.44% |
| 2017 Q3 | 20.47 Billion USD | -2.76% |
| 2017 Q4 | 20.28 Billion USD | -0.93% |
| 2016 Q1 | 23.8 Billion USD | -2.66% |
| 2016 FY | 22.21 Billion USD | -9.16% |
| 2016 Q3 | 18.03 Billion USD | -31.65% |
| 2016 Q4 | 22.21 Billion USD | 23.21% |
| 2016 Q2 | 26.38 Billion USD | 10.82% |
| 2015 Q4 | 24.45 Billion USD | -7.79% |
| 2015 Q1 | 12.68 Billion USD | -6.35% |
| 2015 Q3 | 26.52 Billion USD | 106.98% |
| 2015 Q2 | 12.81 Billion USD | 1.05% |
| 2015 FY | 24.45 Billion USD | 80.61% |
| 2014 Q4 | 13.54 Billion USD | 15.49% |
| 2014 Q3 | 11.72 Billion USD | -1.16% |
| 2014 Q2 | 11.86 Billion USD | -1.25% |
| 2014 Q1 | 12.01 Billion USD | -1.69% |
| 2014 FY | 13.54 Billion USD | 10.81% |
| 2013 FY | 12.22 Billion USD | -11.81% |
| 2013 Q1 | 12.72 Billion USD | -8.21% |
| 2013 Q4 | 12.22 Billion USD | -1.05% |
| 2013 Q2 | 12.74 Billion USD | 0.19% |
| 2013 Q3 | 12.35 Billion USD | -3.09% |
| 2012 Q4 | 13.85 Billion USD | 0.0% |
| 2012 FY | 13.85 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -25810.261% |
| Accuray Incorporated | 423.54 Million USD | -7218.737% |
| Align Technology, Inc. | 2.45 Billion USD | -1163.477% |
| Elevance Health Inc. | 69.52 Billion USD | 55.413% |
| AxoGen, Inc. | 101.16 Million USD | -30541.941% |
| Boston Scientific Corporation | 15.6 Billion USD | -98.629% |
| CVS Health Corporation | 173.09 Billion USD | 82.092% |
| Cardinal Health, Inc. | 48.33 Billion USD | 35.866% |
| Centene Corporation | 58.68 Billion USD | 47.179% |
| DaVita Inc. | 14.87 Billion USD | -108.374% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 43.794% |
| Hologic, Inc. | 4.02 Billion USD | -669.945% |
| Humana Inc. | 30.74 Billion USD | -0.816% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -1645.978% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -250.87% |
| Masimo Corporation | 1.67 Billion USD | -1748.751% |
| McKesson Corporation | 69.04 Billion USD | 55.103% |
| Patterson Companies, Inc. | 1.89 Billion USD | -1535.778% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -307.654% |
| ResMed Inc. | 2 Billion USD | -1443.455% |
| Henry Schein, Inc. | 5.42 Billion USD | -471.919% |
| Teladoc Health, Inc. | 2.06 Billion USD | -1400.172% |
| Universal Health Services, Inc. | 8.15 Billion USD | -280.113% |
| Veeva Systems Inc. | 1.26 Billion USD | -2348.314% |
| Baxter International Inc. | 19.8 Billion USD | -56.492% |
| Becton, Dickinson and Company | 26.98 Billion USD | -14.875% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -1416.388% |
| Stryker Corporation | 21.31 Billion USD | -45.401% |
| Medtronic plc | 39.56 Billion USD | 21.645% |